MCM
DXCM icon

Maryland Capital Management’s DexCom DXCM Stock Holding History

Maryland Capital Management’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,100
Closed -$269K – 228
2022
Q1 		$269K Buy
2,100
+80
+4% +$8.75K 0.02% 214
2021
Q4 		$271K Sell
2,020
-620
-23% -$89.1K 0.01% 229
2021
Q3 		$361K Hold
2,640
– – 0.02% 191
2021
Q2 		$282K Hold
2,640
– – 0.02% 213
2021
Q1 		$237K Hold
2,640
– – 0.02% 224
2020
Q4 		$244K Sell
2,640
-40
-1% -$3.57K 0.02% 203
2020
Q3 		$276K Buy
2,680
+40
+2% +$4.18K 0.02% 175
2020
Q2 		$268K Sell
2,640
-1,060
-29% -$94.8K 0.02% 173
2020
Q1 		$249K Buy
+3,700
New +$230K 0.03% 180

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Maryland Capital Management's DXCM Position: Q2 2022 in Review

Maryland Capital Management sold out of DexCom (DXCM) in Q2 2022, closing a stake of 2,100 shares — an estimated $269K sold.

Maryland Capital Management first reported a position in DXCM in Q1 2020 and held it in 9 quarters. The position peaked at $361K in Q3 2021. 798 funds tracked by Wall St. Rank hold DXCM as of Q2 2022.

  • Maryland Capital Management reported no remaining DexCom position as of Q2 2022 after selling out during the quarter.
  • Maryland Capital Management sold 2,100 DexCom shares in Q2 2022, an estimated $269K.
  • Maryland Capital Management first reported a position in DexCom in Q1 2020 and held it in 9 quarters.
  • Maryland Capital Management's DexCom position peaked at $361K in Q3 2021.
  • 798 funds tracked by Wall St. Rank held DexCom as of Q2 2022.

Based on Maryland Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.